These results suggest that some of these later altered genes (e.g., SMO, POLR2A) might act as driver genes in a significant fraction of NF2-wild-type WHO grade 1 meningiomas (12, 15, 39), further studies being required to confirm this hypothesis. This evidence concerns the gene POLR2A and meningioma.